MutT Homolog 1 (MTH1) maintains multiple KRAS-driven pro-malignant pathways.

作者: A Patel , D G A Burton , K Halvorsen , W Balkan , T Reiner

DOI: 10.1038/ONC.2014.195

关键词:

摘要: Oncogenic RAS promotes production of reactive oxygen species (ROS), which mediate pro-malignant signaling but can also trigger DNA damage-induced tumor suppression. Thus RAS-driven cells require redox-protective mechanisms to mitigate the damaging aspects ROS. Here, we show that MutT Homolog 1 (MTH1), mammalian 8-oxodGTPase sanitizes oxidative damage in nucleotide pool, is important for maintaining several KRAS-driven traits a nonsmall cell lung carcinoma (NSCLC) model. MTH1 suppression KRAS-mutant NSCLC impairs proliferation and xenograft formation. Furthermore, levels modulate KRAS-induced transformation immortalized epithelial cells. expression upregulated by oncogenic KRAS correlates positively with high human tumors. At molecular level, p53-competent cells, loss provokes induction oncogene-induced senescence. In p53-nonfunctional does not produce reduces leads an adaptive decrease levels. Thus, only enables evasion its consequences, function as rheostat oncogene at optimal Accordingly, our results indicate novel critical component KRAS-associated malignancy inhibition likely yield significant tumor-suppressive outcomes

参考文章(53)
P. Rai, T. T. Onder, J. J. Young, J. L. McFaline, B. Pang, P. C. Dedon, R. A. Weinberg, Continuous elimination of oxidized nucleotides is necessary to prevent rapid onset of cellular senescence Proceedings of the National Academy of Sciences of the United States of America. ,vol. 106, pp. 169- 174 ,(2009) , 10.1073/PNAS.0809834106
Justyna Janik, Maja Swoboda, Beata Janowska, Jarosław M. Cieśla, Daniel Gackowski, Janusz Kowalewski, Ryszard Olinski, Barbara Tudek, Elżbieta Speina, 8-Oxoguanine incision activity is impaired in lung tissues of NSCLC patients with the polymorphism of OGG1 and XRCC1 genes. Mutation Research. ,vol. 709, pp. 21- 31 ,(2011) , 10.1016/J.MRFMMM.2011.02.009
Yusaku Nakabeppu, Molecular genetics and structural biology of human MutT homolog, MTH1. Mutation Research. ,vol. 477, pp. 59- 70 ,(2001) , 10.1016/S0027-5107(01)00096-3
Kilian V. M. Huber, Eidarus Salah, Branka Radic, Manuela Gridling, Jonathan M. Elkins, Alexey Stukalov, Ann-Sofie Jemth, Camilla Göktürk, Kumar Sanjiv, Kia Strömberg, Therese Pham, Ulrika Warpman Berglund, Jacques Colinge, Keiryn L. Bennett, Joanna I. Loizou, Thomas Helleday, Stefan Knapp, Giulio Superti-Furga, Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy Nature. ,vol. 508, pp. 222- 227 ,(2014) , 10.1038/NATURE13194
F. Weinberg, R. Hamanaka, W. W. Wheaton, S. Weinberg, J. Joseph, M. Lopez, B. Kalyanaraman, G. M. Mutlu, G. R. S. Budinger, N. S. Chandel, Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity Proceedings of the National Academy of Sciences of the United States of America. ,vol. 107, pp. 8788- 8793 ,(2010) , 10.1073/PNAS.1003428107
Asmita Patel, Anisleidys Muñoz, Katherine Halvorsen, Priyamvada Rai, Creation and validation of a ligation-independent cloning (LIC) retroviral vector for stable gene transduction in mammalian cells. BMC Biotechnology. ,vol. 12, pp. 3- 3 ,(2012) , 10.1186/1472-6750-12-3
Dmitri Wiederschain, Wee Susan, Lin Chen, Alice Loo, Guizhi Yang, Alan Huang, Yan Chen, Giordano Caponigro, Yung-mae Yao, Christoph Lengauer, William R. Sellers, John D. Benson, Single-vector inducible lentiviral RNAi system for oncology target validation. Cell Cycle. ,vol. 8, pp. 498- 504 ,(2009) , 10.4161/CC.8.3.7701
Veronika A. Szalai, Melissa J. Singer, H. Holden Thorp, Site-specific probing of oxidative reactivity and telomerase function using 7,8-dihydro-8-oxoguanine in telomeric DNA. Journal of the American Chemical Society. ,vol. 124, pp. 1625- 1631 ,(2002) , 10.1021/JA0119651
David W. Clark, Tzu Phang, Michael G. Edwards, Mark W. Geraci, Mark N. Gillespie, Promoter G-quadruplex sequences are targets for base oxidation and strand cleavage during hypoxia-induced transcription. Free Radical Biology and Medicine. ,vol. 53, pp. 51- 59 ,(2012) , 10.1016/J.FREERADBIOMED.2012.04.024
Kumar Sanjiv, Marie-Caroline Jacques-Cordonnier, Matthieu Desroses, Anna-Lena Gustavsson, Roger Olofsson, Fredrik Johansson, Evert J. Homan, Olga Loseva, Lars Bräutigam, Lars Johansson, Andreas Höglund, Anna Hagenkort, Therese Pham, Mikael Altun, Fabienne Z. Gaugaz, Svante Vikingsson, Bastiaan Evers, Martin Henriksson, Karl S. A. Vallin, Olov A. Wallner, Lars G. J. Hammarström, Elisee Wiita, Ingrid Almlöf, Christina Kalderén, Hanna Axelsson, Tatjana Djureinovic, Jordi Carreras Puigvert, Maria Häggblad, Fredrik Jeppsson, Ulf Martens, Cecilia Lundin, Bo Lundgren, Ingrid Granelli, Annika Jenmalm Jensen, Per Artursson, Jonas A. Nilsson, Pål Stenmark, Martin Scobie, Ulrika Warpman Berglund, Thomas Helleday, Helge Gad, Tobias Koolmeister, Ann-Sofie Jemth, Saeed Eshtad, Sylvain A. Jacques, Cecilia E. Ström, Linda M. Svensson, Niklas Schultz, Thomas Lundbäck, Berglind Osk Einarsdottir, Aljona Saleh, Camilla Göktürk, Pawel Baranczewski, Richard Svensson, Ronnie P.-A. Berntsson, Robert Gustafsson, Kia Strömberg, MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool Nature. ,vol. 508, pp. 215- 221 ,(2014) , 10.1038/NATURE13181